- DNA Repair Deficiency as Circulating Biomarker in Prostate Cancer.
- Roviello G, Generali D, Gatti M, Riboli B, Paganini L, Nesi G, Catalano M.
- Front Oncol. 2023 Jan 12;12:1115241. doi: 10.3389/fonc.2023.1115241.
- Review
- Free Full Text
- Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches.
- Posdzich P, Darr C, Hilser T, Wahl M, Herrmann K, Hadaschik B, Grünwald V.
- Cancers (Basel). 2023 Jan 11;15(2):461. doi: 10.3390/cancers15020461.
- Review
- Free Full Text
- Management of patients with advanced prostate cancer in Japan: 'real-world' consideration of the results from the Advanced Prostate Cancer Consensus Conference.
- Fujita K, Suzuki H, Hinata N, Miura Y, Edamura K, Tabata KI, Arai G, Matsubara N, Yasumizu Y, Kosaka T, Oya M, Sugimoto M.
- Transl Androl Urol. 2022 Dec;11(12):1771-1785. doi: 10.21037/tau-22-396.
- PMID: 36632151
- PubMed abstract
•• Commentary:
Assessment of real-world application of advanced prostate cancer management in Japan.
- PMID: 36632149
- PubMed abstract
- Free Full Text